Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP003854priorityCriticalpatent/ECSP003854A/en
Publication of ECSP003854ApublicationCriticalpatent/ECSP003854A/en
102100021339Multidrug resistance-associated protein 1Human genes0.000abstract1
108010066052multidrug resistance-associated protein 1Proteins0.000abstract1
Landscapes
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención se refiere además a un procedimiento para la inhibición de la MRP1 en un mamífero, que comprende la administración a un mamífero necesitado de ello de una cantidad eficaz de un compuesto de la fórmula I:The present invention further relates to a process for the inhibition of MRP1 in a mammal, which comprises administration to a mammal in need thereof of an effective amount of a compound of the formula I:
ECSP0038542000-12-222000-12-22
PROCEDURES AND COMPOUNDS FOR THE INHIBITION OF THE MRP 1
ECSP003854A
(en)
processes for the preparation of 3-(1-methyl-3-indolyl)-4-(1-methyl-6-nitro-3-indolyl)-1h-pyrrole-2,5-dione, in amorphous form and pharmaceutical composition